Browse 21 Biotechnology companies funded by Matrix Partners China. See funding amounts, founder contacts, and investment details.
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.
Adlai Nortye is a clinical-stage biopharmaceutical company that deveops cancer treatments for diverse tumor types.
PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring health and curing disease through autophagy.
Alioth focuses on the development and application of technical products for pharmaceutical process technology.
Weiyuan Synthetic Biotechnology specializes in the manufacturing of food, feed and materials based on synthetic biology technology.
Jiajin Biotech is a pharmaceutical R&D service provider.
KYinno is a drug development company that is dedicated to oncology drug development with a focus on immune treatments against cancer.
D3 Bio is a biotechnology company focusing on the development and registration of medicines.
GRIT Biotechnology develops tumor infiltration lymphocytes immunotherapy for solid tumors.
RootPath is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
Zhongke Guosheng is research and development firm that designs and manufactures furan-based bio-based materials.
Inces is a biotech enterprise focusing on bio-separation technology.
Lingyi Bio is a rare disease animal model functional verification platform and gene therapy developer.
Zenshine Pharma is a clinical-stage biopharmaceutical company with a focus on small molecule drugs for cancer and autoimmune diseases.
Onechip Bioelectronics develops biosensor chips and nanomaterials.
Qihan Biotech is a gene-editing organ transplantation technology developer.
Protoga is a biotech firm that focused on the development of innovative microalgae biosynthesis technology.
Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.
Excell Biology is a supplier of raw materials to the biopharmaceutical and precision medicine industries.
Lansion Biotechnology is specialized in research & development, production, sell, services of in vitro diagnostic reagents and devices.
View all companies funded by Matrix Partners China across every industry and funding stage.
View Full Matrix Partners China Portfolio